The bill amends Chapter 5-37.8 of the General Laws, known as the "Protections for Healthcare Providers Act," by adding a new section that establishes prescriptive protections for providers involved in legally protected healthcare activities. Specifically, it allows the prescription label for medication abortion prescription drugs to include the name of the dispensing healthcare practice instead of the name of the dispenser.

The bill defines "medication abortion prescription drugs" as substances used in the course of medical treatment intended to induce the termination of a pregnancy, including, but not limited to, mifepristone and misoprostol. The act is set to take effect immediately upon passage.